首页> 外文OA文献 >The cost of multiple sclerosis in Norway – (and how certain can we be?)
【2h】

The cost of multiple sclerosis in Norway – (and how certain can we be?)

机译:挪威多发性硬化症的代价 - (以及我们可以确定多少?)

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The research question initially formulated for this study was to attempt to set a numerical target for the total yearly cost of MS to the Norwegian society, and relate the cost and patients´ experienced quality of life to illness severity. As work progressed, the question of how much confidence may be put in this kind of information in Norway as for today turned into another main issue. It turned out that much of the information that could be used for our study was so imprecise or unreliable that giving an impression that the information could be used to give an acceptably precise single estimate of the cost of MS to the Norwegian society would be seriously misleading. Therefore both “conservative” and “best” estimates are given. A conservative estimate of the yearly cost of MS to the Norwegian society around year 2002 is NOK 1 836 million. A best estimate is NOK 4 033 million, more than twice the conservative estimate. Mainly three factors account for the difference between the estimates: Uncertainty on what elements should be included in cost-of-illness studies, uncertainty on how some cost elements should be valued, and a combination of differences in information on the same phenomena in different sources of information and the researchers´ choices on how to handle them. For decision making purposes the combined effect of differences in information from different sources and the researchers´ choices on how to handle them is most grave since it will usually go unrecognized.When related to illness severity, the total cost per patient to society seem to increase, and the patients experienced quality of life to decrease, in a close to linear fashion with increasing EDSS-levels 1. However, a warning should be raised that because of the uncertainties as those mentioned, Norway probably has a long way to go before studies like ours in general might be regarded as providing acceptable information for decisions as important as those that have to be made in the health sector. 1 The EDSS, Kurtzke`s “Expanded Disability Status Scale”, is the most common tool used to express illness severity in MS. The scale ranges from 0 (no disability) to 10 (dead due to MS) and is divided in 20 half-point steps.
机译:最初为该研究制定的研究问题是试图为挪威社会每年为MS的总费用设定一个数字目标,并将该费用和患者的生活质量与疾病的严重程度联系起来。随着工作的进行,到今天,挪威对这种信息的信任程度可能会变成另一个主要问题。事实证明,可用于我们的研究的许多信息是如此不精确或不可靠,以至于给人留下印象,即该信息可用于对挪威社会的MS成本进行可接受的,准确的单一估计,这将造成严重的误导。 。因此,给出了“保守”和“最佳”估计。保守估计,到2002年左右,MS对挪威社会的年度成本为18.36亿挪威克朗。最佳估计为40.33亿挪威克朗,是保守估计的两倍多。估计之间的差异主要由三个因素造成:疾病成本研究中应包括哪些要素的不确定性,某些成本要素应如何估价的不确定性以及不同来源中同一现象的信息差异的组合信息以及研究人员在如何处理这些信息方面的选择。出于决策目的,来自不同来源的信息差异以及研究人员对如何处理这些信息的选择的综合影响是最严重的,因为通常无法识别。当与疾病严重度相关时,每位患者对社会的总成本似乎在增加,并且患者的生活质量随着EDSS等级1的提高而以接近线性的方式下降。但是,应该提出警告,由于上述不确定因素,挪威在研究之前可能还有很长的路要走一般而言,像我们这样的人可能会被视为为卫生领域必须做出的重要决定提供可接受的信息。 1 EDSS是Kurtzke的“扩展残疾状况量表”,是用于表达MS中疾病严重程度的最常用工具。刻度范围从0(无残障)到10(由于MS而死),分为20个半点步长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号